Top compounds associated with response to TEFM


Feature Type Standardized
Nominal ANOVA
mRNA AZD8055 GDSC1000 pan-cancer AAC 0.1 0.002
mRNA YM-155 CTRPv2 pan-cancer AAC 0.11 0.003
mRNA Methotrexate CTRPv2 pan-cancer AAC 0.11 0.003
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.004
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.004
mRNA procarbazine CTRPv2 pan-cancer AAC -0.11 0.006
mRNA BRD-K16147474 CTRPv2 pan-cancer AAC -0.11 0.006
mRNA BRD-K90370028 CTRPv2 pan-cancer AAC -0.15 0.007
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.096 0.007
mRNA Vorinostat gCSI pan-cancer AAC 0.14 0.007
Download CSV